AG真人官方

AAR Corp. (FY ended 31 May 2025) reported strong top-line momentum. Consolidated sales rose $461.6 M, or 19.9%, driven mainly by commercial demand and the late-FY24 Product Support acquisition. Commercial revenue grew $338.2 M (+20.6%); government revenue increased $123.4 M (+18.1%). Segment mix: Parts Supply 40% of sales, Repair & Engineering 32%, Integrated Solutions 25%, Expeditionary Services 3%.

Key portfolio moves included the sale of the Landing Gear Overhaul business to GA Telesis for $48 M, producing a $71.1 M divestiture loss, and a $2.1 M gain on exit of an Indian MRO JV. Integration of FY24鈥檚 Product Support buy and FY23鈥檚 Trax software investment is yielding cost synergies and digital upselling opportunities.

Growth pipeline: new multi-year distribution deals (Unison, Chromalloy, Ontic), an extended FTAI Aviation USM agreement (CFM56 through 2030) and two U.S. Navy P-8A support contracts. Firm backlog stands at $537.2 M (鈮�75% recognizable in FY26). Airframe MRO capacity is expanding via 114 k sq ft Miami and 80 k sq ft Oklahoma City hangars, targeted for service within 12-18 months (Miami slightly delayed by permitting).

Government exposure remains meaningful: U.S. government agencies and contractors accounted for $687.6 M, 24.7% of revenue. Shares outstanding on 30 Jun 2025 were 35.85 M; non-affiliate market value was ~$2.43 B (11 Nov 2024 close). Workforce totals 5,600 employees and 500 contractors.

GSK plc filed a Form 6-K detailing activity under its ongoing share repurchase programme. On 09 July 2025 the company repurchased 473,780 ordinary shares (nominal value 31鈪損) through Merrill Lynch International at prices between 1,403.50p 鈥� 1,430.00p, resulting in a volume-weighted average price of 1,422.07p. The shares will be held in treasury.

Since the non-discretionary agreement started on 4 June 2025, GSK has acquired 11,418,412 shares. Following the latest purchase, treasury holdings rise to 229,552,795 shares, representing 5.62 % of total voting rights. Shares in issue (excluding treasury) now stand at 4,085,829,055.

• Daily buyback equates to roughly 0.012 % of outstanding shares; cumulative purchases since 4 June equal ~0.28 %.
• Removal of shares from circulation slightly improves earnings per share and signals management鈥檚 continued capital-return commitment.
• Updated share count (4.09 bn) should be used for ownership disclosure calculations under FCA DTR rules.

Chunghwa Telecom Co., Ltd. (NYSE: CHT) filed a Form 6-K to inform investors of its upcoming second-quarter 2025 earnings teleconference.

• Date: 5 August 2025
• Time: 15:00鈥�16:00 Taipei time
• Access to materials: From 14:30 at https://www.cht.com.tw/chtir and the TWSE MOPS portal

The filing contains no financial metrics or guidance; it is strictly an administrative notice so analysts and shareholders can schedule attendance and review the presentation in advance.

Vigil Neuroscience, Inc. (NASDAQ: VIGL) has mailed a Definitive Proxy Statement (DEFM14A) dated June 30, 2025 that seeks stockholder approval for its proposed acquisition by Sanofi. The transaction is structured as a cash merger in which Sanofi鈥檚 wholly owned subsidiary Vesper Acquisition Sub Inc. will merge with and into Vigil. At closing, Vigil stockholders will receive (i) $8.00 per share in cash, less applicable withholding, and (ii) one contingent value right (CVR) per share. Each CVR entitles the holder to an additional $2.00 in cash if the first commercial sale of VG-3927 occurs on or before December 31, 2035, as detailed in the CVR Agreement that Sanofi will execute at or prior to closing.

The company鈥檚 Board of Directors unanimously approved the Merger Agreement on May 21, 2025, concluded that the transaction is fair and advisable, and recommends that stockholders vote FOR both proxy proposals: (1) adoption of the Merger Agreement (the 鈥淭ransaction Proposal鈥�) and (2) permission to adjourn the meeting to solicit additional votes if necessary (the 鈥淎djournment Proposal鈥�). The special meeting will be held virtually on August 4, 2025 at 8:30 a.m. ET. A simple majority of the outstanding common shares is required to approve the merger, while a majority of votes cast is required to approve any adjournment.

Sanofi has entered into Voting and Support Agreements with Chief Executive Officer Ivana Magov膷evi膰-Liebisch and entities affiliated with Atlas Venture, together holding approximately 16.54 % of Vigil鈥檚 voting power, committing them to vote in favor of the merger. Holders of Series A Non-Voting Convertible Preferred Stock are not entitled to vote on either proposal. Common stockholders who continuously hold shares through the effective time and who dissent properly under Delaware General Corporation Law 搂262 will be entitled to appraisal rights.

The definitive proxy reiterates that neither the SEC nor any state regulator has passed on the merits of the merger and warns that representations to the contrary are a criminal offense. It instructs stockholders on how to cast their votes, outlines virtual attendance procedures, and provides contact information for obtaining additional proxy materials. The document also highlights that failure to give voting instructions for shares held in 鈥渟treet name鈥� will result in those shares not being voted.

If approved, Vigil will become a wholly owned subsidiary of Sanofi, and its common stock will cease trading. The CVR structure directly ties $2.00 of potential additional value to the commercial success of VG-3927, creating a risk-adjusted upside for stockholders while limiting Sanofi鈥檚 upfront cash outlay.

Chunghwa Telecom's subsidiary, Honghwa International Corporation, has reported two significant real estate transactions with its parent company:

Transaction 1 - Disposal of Right-of-Use Asset:

• Property: 2F office space in Taichung City (19 pings)
• Monthly rent: NT$12,000 (NT$632 per ping)
• Total transaction: NT$72,000
• Right-of-use asset value: NT$65,322
• Expected gain: NT$2,966

Transaction 2 - Acquisition of Right-of-Use Asset:

• Properties: 289 store locations across Taiwan
• Total area: 17,846.12 pings
• Monthly average rate: NT$503 per ping
• Total transaction: NT$53,831,490
• Right-of-use asset value: NT$51,049,405

Both transactions were approved by the Board of Directors and Audit Committee on June 18, 2025, reflecting strategic changes in Honghwa's operational footprint.